Topics

Namenda Product Hopping Settlement Surpasses Most Recent DOJ Agreements

18:10 EDT 28 Oct 2019 | SCRIP

Direct purchasers' $750m settlement with Allergan is at least the second involving product hopping claims; only one DOJ settlement surpassed...

      

Related Stories

 

Original Article: Namenda Product Hopping Settlement Surpasses Most Recent DOJ Agreements

NEXT ARTICLE

More From BioPortfolio on "Namenda Product Hopping Settlement Surpasses Most Recent DOJ Agreements"

Quick Search